Cholesterol-targeting interventions
The company develops simple, direct interventions targeting toxic forms of cholesterol using rationally designed molecules.
Source: LinkedIn company description · Retrieved October 13, 2026
Cyclarity Therapeutics pursues treatments addressing underlying causes of age-related disease.
The company develops interventions targeting toxic forms of cholesterol using rationally designed molecules. The stated disease areas include atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company develops simple, direct interventions targeting toxic forms of cholesterol using rationally designed molecules.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 19, 2026 and September 21, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.